FACTS
Malaria is rife in many tropical and some subtropical countries and this preventative disease causes about 2.7 million deaths every year. Most of the deaths are in Africa, where 80 - 90% of malaria cases occur. About 500 million people contract malaria every year¹. Like all debilitating diseases there is no discrimination. A staggering 67% of this figure is for Africa alone². Of the 90 odd countries infected, 47 countries are in Africa.
Those affected worldwide represent about 43% of world population, with African nations being affected at an astounding 28.6%³.

Every 12 hours approximately 5000 people will die from malaria. Of this figure, approximately half will be children and approximately 1300 will be infants under 12 months old. Pregnant women are more susceptible to the malaria parasite and die at double the rate than non-pregnant women.
To make this figure more astounding –thirteen to fifteen children will get infected every second and three will die every 20 – 30 seconds!³

¹ WHO journal 2003
² Unicep 2003
³ PSI journal 2002

TRAVEL TO MOSQUITO AREAS
Malaria is the infectious disease that poses the largest threat to a person travelling to tropical and sub-tropical areas, especially rural areas. The use of preventative medication must commence prior to departure.

Malaria is a parasitic disease that is transmitted to humans by the female Anopheline mosquito. There are four species of the parasite plasmodium which cause malaria namely: P.falciparum, P.vivax, P.ovale and P.malariae. The life cycle within its host comprises a hepatic phase (liver infestation) and an erythrocytic phase (red blood cell infestation). The female usually lays from 50 to 500 eggs and requires blood to feed them.

SYMPTOMS
The symptoms of malaria are non-specific and irregular fever, chills, headache and malaise occurs. Vomiting occurs in approximately 20% of patients and diarrhoea in less than 5%. Malaria is so common that anyone who has been in a malaria area in the previous two months (usual incubation period being two weeks) should be considered to have active infection until proved otherwise. Diagnosis is made by a simple blood test.

The strategy for the prevention of malaria is to interrupt the life cycle of the parasite in one of two ways: by preventing injection of the parasite by the Anopheline mosquito (personal protective measures) and/or interfering with the life cycle within the human host (prophylactic medication).
Excerpt written by Dr. Myron Elias BScMBBChDipPEC (SA) from the book: The DIY 4x4 Guide To Africa by Louie Greeff

WHY HOMEOPATHIC ANTI-MALARIA PROPHYLACTICS?
Louie Greeff, the co-founder and chairman of FOOD AGAINST DISEASES has traveled Africa for the past 17 years. At the beginning of his travels he took chloroquinine products and still got malaria. He also suffered tremendously from chloroquine side effects and decided to experiment with other conventional drugs, too no avail.
A chance meeting with a renowned homeopath in 1989, changed his way about conventional malaria drugs and his experimentation with various homeopathic ingredients made him realise there was an effective alternative. At the end of 1989, he improved on his formula and it now works for algid and cerebral malaria.
His current formula has worked extremely well for the past 13 years and there have been no negative reports from users. He has given the Malariatabs to travelers, overlanders, aid workers, rural communities and migrant workers who return home to rural areas.

Malaria is caused by four species of parasitic protozoa, being; P.vivax, P.ovale, P.malariae and P.falciparum (one-celled organisms) that infect human red blood cells. Malriatabs work on all four species and in-depth research, plus ongoing clinical trails need to be conducted on the effective stabilizing of red blood cells.

For many years Mr. Greeff was plagued by recurring malaria and he has successfully treated himself with Malaria Complex, which is registered with the Medical Control Council (Classification A 34). He has never had another bout since 1993.

Separate homeopathic anti-malaria prophylactics are supplied to individuals in quantities of 400 tablets, which is sufficient for one year. Larger quantities are supplied to clinics and/or a trained person at rural villages who dispense quantities weekly or monthly.